LEARN. LAUNCH. FLY.

Mtech's Mission

    The mission of the Maryland Technology Enterprise Institute (Mtech), a unit of the A. James Clark School of Engineering at the University of Maryland, is to:

    • Educate the next generation of technology entrepreneurs;
    • Create successful technology ventures; and
    • Connect Maryland companies with university resources to help them succeed.

    Mtech has built a comprehensive entrepreneurship and innovation ecosystem at the University of Maryland. Its programs arm top students from around the world with the knowledge of how to successfully launch companies and guide aspiring and existing entrepreneurs through the entire lifecycle of launching and maintaining technology-based ventures.

    Read more about Mtech >





    < MTECH

    MARYLAND TECHNOLOGY ENTERPRISE INSTITUTE > News

    ASPIRE is a grant program for undergraduate researchers working with Clark School faculty on projects with commercial potential

    News

    MTECH Facility Assists in Smallpox Therapy Development

    MTECH Facility Assists in Smallpox Therapy Development

    BioFactura Inc. is developing a therapy for smallpox using the University of Maryland’s Bioprocess Scale-Up Facility.

    The Rockville-based company is collaborating with Fort Detrick in the laboratories of the U.S. Army Medical Research Institute of Infectious Diseases, in hopes of commercializing a product within four years. BioFactura will use the Bioprocess Scale-Up Facility to work on large-scale drug manufacturing.

    The virus, transmitted by contact or through the air, can survive in dust, bedding and clothing. “Although anthrax proved to be a deadly bioterror agent, a smallpox attack could be devastating,” said BioFactura’s Chief Science Officer Darryl Sampey.

    The threat of smallpox virus use at the hands of terrorists has led the government to fund extensive research to develop safer vaccines. The Centers for Disease Control and Prevention labels the virus a “Category A” agent, which presents the “greatest potential threat for harming the public.”

    With help from the university’s Bioprocess Scale-Up Facility a cure for smallpox may be possible. “It would be one of the only smallpox therapies known to man, and be one of the largest products to come out of our lab,” said Ben Woodard, director of the Scale-Up Facility.

    More: http://www.mtech.umd.edu/news/press_releases/BSF_BioFactura.html

    February 8, 2006


    Prev   Next